QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

AAPG

QT56Ascentage Pharma Group International
NASDAQ·Healthcare·Biotechnology·China
Latest market price
17.12
+0.03+0.18%
OverviewShort InterestFilings
AAPGQT56Ascentage Pharma Group International·NASDAQ
OverviewShort InterestFilings
17.12+0.18%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-2.64
Insider Own0.64%
Shs Outstand373.56M
Perf Week0.06%
Market Cap1.59BForward P/E-EPS next Y-0.42Insider Trans0.15%Shs Float-Perf Month-9.85%
Enterprise Value1.52BPEG0.05EPS next Q-0.06Inst Own-Short Float-Perf Quarter-22.32%
Income-182546683.00P/S18.94EPS this Y60.16%Inst Trans-Short Ratio-Perf Half Y-41.85%
Sales83.87MP/B8.08EPS next Y60.26%ROA-31.03%Short Interest-Perf YTD-34.76%
Book/sh0.51P/C-EPS next 5Y-ROE-123.61%52W High48.44 -64.66%Perf Year-45.89%
Cash/sh0.94P/FCF-EPS past 3/5Y-ROIC-33.71%52W Low16.92 1.18%Perf 3Y-
Dividend Est.-EV/EBITDA-9.22Sales past 3/5Y36.01% 108.07%Gross Margin84.09%Volatility2.65% 4.09%Perf 5Y-
Dividend TTM-EV/Sales18.08EPS Y/Y TTM-209.11%Oper. Margin-210.42%ATR (14)0.74Perf 10Y-
Dividend Ex-Date-Quick Ratio1.77Sales Y/Y TTM58.09%Profit Margin-216.74%RSI (14)34.47Recom2.00
Dividend Gr. 3/5Y-Current Ratio1.79EPS Q/Q36.21%SMA20-6.96%Beta1.11Target Price40.00
Payout0.00%Debt/Eq1.49Sales Q/Q327.27%SMA50-19.28%Rel Volume1.85Prev Close17.09
Employees567LT Debt/Eq0.57EarningsAug 26SMA200-38.51%Avg Volume6.92KPrice17.12
IPO DateJan 24, 2025Option/ShortYes / YesEPS/Sales Surpr.21.69% 11.36%Net Debt/EBITDA0.44Volume12,802Change0.18%
Analyst Ratings
DateActionAnalystRatingTarget
Apr-24-26InitiatedDeutsche BankBuy$40
Dec-04-25InitiatedOppenheimerOutperform$45
Nov-24-25InitiatedTruistBuy$51
Nov-05-25ReiteratedPiper Sandler$48
Latest News
Jun-15-26
Jun-15-2602:46AM
Reported Sunday, Ascentage Pharma's Olverembatinib And Lisaftoclax Demonstrate Strong Clinical Data Across Chronic Myeloid Leukemia, Ph+ ALL And CLL/SLL In Seventeen Updates At EHA2026 CongressBenzinga
Jun-10-26
Jun-10-2602:06PM
B. Riley Securities Initiates Coverage On Ascentage Pharma Group with Buy Rating, Announces Price Target of $45Benzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue21578136
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A17184
Gross Profit19859132
Selling, General and Administrative Excl. Other1317353
Research and Development287151132
Other Operating Expense10-1
Operating Income-220-164-51
Interest Expense879
Unusual Expense
———
Non-Operating Income (Expense)00-5
Net Income Before Taxes-227-167-55
Income Taxes211
Consolidated Net Income-228-168-56
Net Income From Continuing Operations-229-168-56
Net Income-228-168-56
EPS (Recurring)-2.64-1.89-0.74
EPS (Basic, Before Extraordinaries)-2.64-1.89-0.74
EPS (Diluted)-2.64-1.89-0.74
EBITDA-197-152-33
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio7.4129.94—
Gross Margin92.0975.6497.06
Operating Margin-102.33-210.26-37.50
Net Margin-106.05-215.38-41.18
Shares Outstanding938976
Market Capitalization1,5922,335—
Operating Lease Expense
———
Insider Trading Volume
$21.16$19.12$17.08$15.04$13.00● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Zhai YifanChief Medical OfficerMay 21 '26Option Exercise0.00283,89601,193,569May 22 12:00 AM
Yang DajunChairman and CEOMay 21 '26Option Exercise0.00281,06701,193,569May 22 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR